Japanese Society for Transplantation and Cellular Therapy

English

History of JSTCT

Update: August 18, 2022

The Japanese Society for Transplantation and Cellular Therapy (JSTCT) was initiated as a nationwide gathering to promote friendly discussions on bone marrow transplantation in 1978, which was renamed as the Bone Marrow Transplantation Study Group in 1980. At the 13th Annual Meeting in 1991, when the 2nd Annual Meeting of the Asia-Pacific Blood and Marrow Transplantation Group (APBMT) was jointly organized, the group expanded its membership to include nurses and other co-medical professional; furthermore, bylaws and elected officers were implemented. At the 19th Annual Meeting in 1996, the group set up the Japan Society for Hematopoietic Cell Transplantation (JSTCT), and in 2006, the JSTCT was approved as an NGO under Japanese law. Currently, JSTCT comprises 4,500 members including physicians, nurses, other co-medical professionals, donors and clinical coordinators, volunteers, and pharmaceutical companies. JSTCT has primarily acted as the academic society for transplant clinicians, but it recently expanded its interest in cell therapy and regenerative medicine. The core activities of the JSTCT include organizing an annual congress, publishing quarterly medical journals (JCT) and JSTCT Letters, managing data centers for transplant patient and donor registration, publishing the Annual Report of the Nationwide Survey for transplant recipients, promoting more than 20 working groups, guiding more than 20 committees, and publishing multiple guidelines for hematopoietic stem cell transplantation. The members of the JSTCT play key roles in guiding the Japan Marrow Donor Program (JMDP), Japan Cord Blood Bank Network (JCBBN), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), and Worldwide Network for Blood and Marrow Transplantation (WBMT). The JSTCT also works to deepen relationships with other national and international academic societies. 

Copyright © JSTCT All Rights Reserved.
To Top